Blood test could reveal transition to cancer in people at risk

Scientists have devised an accurate and sensitive way to test blood to see if a pre-cancerous condition is escalating to outright cancer — potentially enabling treatment early in tumor development...

Early Detection of Cancer Conference set for Oct. 18-20

Leaders in early detection and top scientists and innovators in cancer research and bioengineering will gather in Portland, Oregon, Oct. 18-20, 2022, for the seventh in the series organized by the...

Time to accelerate early detection research

Cancer early detection research is poised to transform patient survival, but significant hurdles stand in the way of translating new findings into clinical application, leaders of the field assert in...

Multi-cancer early detection is on the horizon

Before cancers become deadly, signs of their presence can show up in escaped strands of DNA and other tell-tale molecules. Technical leaps are making it possible to find these signals in blood,...

Highlights from the Fifth Early Detection of Cancer Conference

Advancing the early detection of lethal cancers is fundamental to treating patients more effectively. One of the most important factors in cancer survival is diagnosis at an early stage. Screening...

Early detection: a powerful way to improve cancer survival

Advancing the early detection of lethal cancers is fundamental to treating patients more effectively. But the path forward is not easy to see. It will require multi-disciplinary collaborations,...

Cancer genome study reveals big window for early detection

Tell-tale DNA errors arise years before tumors become dangerous. For cancers that can’t currently be detected early, a new discovery suggests there may be a large window of time in which to look...

Bringing together the leaders in cancer early detection

The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...

Oregon’s colonoscopy trailblazer steps into new leadership role

Colorectal screening, primarily by colonoscopy, contributed to a steep drop in cancer incidence (Yang et al. 2014). David Lieberman, M.D., professor and head of gastroenterology and hepatology in...